Business
Chiasma: The product is good. This was a strategic decision by Roche to be less involved in hormone-based drugs. – Roche AG (SWX:...
Hi, what are you looking for?
Chiasma: The product is good. This was a strategic decision by Roche to be less involved in hormone-based drugs. – Roche AG (SWX:...
– Synribo received provisional approval in 2012 subject to additional clinic trial data. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that the U.S. Food and Drug...
– Yosef Maiman is demanding the shares and a NIS 50 million (about $14 million) injection, double what Lauder is offering, say sources close...
– More stable material is ideal for small appliance, electronics and injection mold applications. Stratasys Ltd. (Nasdaq: SSYS) Yestarday debuted the second generation of...
– Insuline has developed a medical device that increases insulin absorption. – – Insuline Medical Ltd. (TASE: INSL), developer of a medical device that improves the rate...